Chargement en cours...
Improved nonviral cancer suicide gene therapy using survivin promoter-driven mutant Bax
Suicide gene vectors are being developed in many laboratories as an attractive approach to cancer therapy. However, the development of these therapies is hampered by safety concerns and limitations of efficacy. The use of tumor-specific promoters, such as survivin promoter, can provide much needed s...
Enregistré dans:
| Publié dans: | Cancer Gene Ther |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2009
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7219470/ https://ncbi.nlm.nih.gov/pubmed/19816523 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/cgt.2009.63 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|